n/a 0.0 0.0%
Last Trade -
| Market Cap | ÂŁn/a |
| Enterprise Value | ÂŁn/a |
| Revenue | ÂŁn/a |
| Position in Universe | th / 6651 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012E | 2013E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Bionoid Pharma Inc., formerly Bronya International Corp., is a medical device company. The Company develops and markets medical devices and technologies for the orthopedic and pain management markets. The Company develops and commercializes a platform called muscle pattern recognition (MPR), a clinical tool for the analysis of muscle function in patients presenting with back pain. MPR provides information regarding muscle recruitment patterns in patients suffering from neck and back pain that can assist healthcare professionals in the evaluation and treatment of neck and back injuries and illnesses. The Company, through BIOflex Medical Magnetics, Inc., develops and sells magnetic therapy devices. The Company sells its products through several channels, including Web-based sales; corporate partnerships; direct response television (DRTV); retail distribution; Internet catalogs, and through a network of distributors across the world.
| Last Annual | December 31st, 2011 |
| Last Interim | September 30th, 2012 |
| Incorporated | June 27, 2006 |
| Public Since | February 4, 1998 |
| No. of Shareholders: | 290 |
| No. of Employees: | 13 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 2,442,397 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 17011 Beach Blvd Ste 900, HUNTINGTON BEACH, 92647-5998, United States |
| Web | |
| Phone | +1 714 8412670 |
| Contact | () |
| Auditors | Farber Hass Hurley LLP |
As of , shares in Bionoid Pharma Inc are trading at n/a, giving the company a market capitalisation of ÂŁn/a. This share price information is delayed by 15 minutes.
Shares in Bionoid Pharma Inc are currently trading at n/a and the price has moved by 2.20k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bionoid Pharma Inc price has moved by 1.69k% over the past year.
There are no analysts currently covering Bionoid Pharma Inc.
Bionoid Pharma Inc is scheduled to issue upcoming financial results on the following dates:
Bionoid Pharma Inc does not currently pay a dividend.
Bionoid Pharma Inc does not currently pay a dividend.
Bionoid Pharma Inc does not currently pay a dividend.
To buy shares in Bionoid Pharma Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Bionoid Pharma Inc are currently trading at n/a, giving the company a market capitalisation of ÂŁn/a.
Here are the trading details for Bionoid Pharma Inc:
We were not able to load our ranking data for Bionoid Pharma Inc
We were not able to load any forecast data for Bionoid Pharma Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bionoid Pharma Inc. Over the past six months, the relative strength of its shares against the market has been 1.62k%. At the current price of n/a, shares in Bionoid Pharma Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Bionoid Pharma Inc.
Bionoid Pharma Inc's management team is headed by:
Here are the top five shareholders of Bionoid Pharma Inc based on the size of their shareholding:
